Ontology type: schema:ScholarlyArticle
2011-12-03
AUTHORSPaul M. McKie, Tomoko Ichiki, John C. Burnett
ABSTRACTThe natriuretic peptides, specifically atrial natriuretic peptide (ANP), are increasingly recognized to play a fundamental role in blood pressure (BP) regulation. This role in BP regulation reflects the pluripotent cardiorenal actions of ANP, which include diuresis, enhancement of renal blood flow and glomerular filtration rate, systemic vasodilatation, suppression of aldosterone, and inhibition of the sympathetic nervous system. These actions of ANP, in addition to recent human studies demonstrating an association of higher plasma ANP with lower risk of hypertension, support the development of an ANP-based therapy for hypertension. M-ANP is a novel ANP-based peptide that is resistant to proteolytic degradation and possesses greater BP-lowering, renal function–enhancing, and aldosterone-suppressing properties than native ANP. In an animal model of hypertension, M-ANP lowers BP via multiple mechanisms, including vasodilatation, diuresis, and inhibition of aldosterone. Importantly, M-ANP enhances both glomerular filtration rate and renal blood flow despite reductions in BP. The pluripotent BP-lowering actions and concomitant enhancement of renal function associated with M-ANP are highly attractive characteristics for an antihypertensive agent and underscore the therapeutic potential of M-ANP. M-ANP currently is heading into clinical testing, which may advance this novel strategy for human hypertension. More... »
PAGES62-69
http://scigraph.springernature.com/pub.10.1007/s11906-011-0244-5
DOIhttp://dx.doi.org/10.1007/s11906-011-0244-5
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1012051007
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/22135207
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aldosterone",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antihypertensive Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Atrial Natriuretic Factor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biological Availability",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Blood Pressure",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Evaluation, Preclinical",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glomerular Filtration Rate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hypertension",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Natriuresis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Renal Circulation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Sympathetic Nervous System",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Therapies, Investigational",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Vasodilation",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Mayo Clinic, Division of Cardiovascular Diseases, 200 First Street SW, 55905, Rochester, MN, USA",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Mayo Clinic, Division of Cardiovascular Diseases, 200 First Street SW, 55905, Rochester, MN, USA"
],
"type": "Organization"
},
"familyName": "McKie",
"givenName": "Paul M.",
"id": "sg:person.01271304603.22",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271304603.22"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA"
],
"type": "Organization"
},
"familyName": "Ichiki",
"givenName": "Tomoko",
"id": "sg:person.01100245546.46",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100245546.46"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA"
],
"type": "Organization"
},
"familyName": "Burnett",
"givenName": "John C.",
"id": "sg:person.01001266776.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/978-3-540-68964-5_15",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002318921",
"https://doi.org/10.1007/978-3-540-68964-5_15"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00109-010-0641-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045002962",
"https://doi.org/10.1007/s00109-010-0641-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ng.361",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041461900",
"https://doi.org/10.1038/ng.361"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ng.328",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035621233",
"https://doi.org/10.1038/ng.328"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nbt0806-942",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032133391",
"https://doi.org/10.1038/nbt0806-942"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/378065a0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015449350",
"https://doi.org/10.1038/378065a0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrd2399",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051687311",
"https://doi.org/10.1038/nrd2399"
],
"type": "CreativeWork"
}
],
"datePublished": "2011-12-03",
"datePublishedReg": "2011-12-03",
"description": "The natriuretic peptides, specifically atrial natriuretic peptide (ANP), are increasingly recognized to play a fundamental role in blood pressure (BP) regulation. This role in BP regulation reflects the pluripotent cardiorenal actions of ANP, which include diuresis, enhancement of renal blood flow and glomerular filtration rate, systemic vasodilatation, suppression of aldosterone, and inhibition of the sympathetic nervous system. These actions of ANP, in addition to recent human studies demonstrating an association of higher plasma ANP with lower risk of hypertension, support the development of an ANP-based therapy for hypertension. M-ANP is a novel ANP-based peptide that is resistant to proteolytic degradation and possesses greater BP-lowering, renal function\u2013enhancing, and aldosterone-suppressing properties than native ANP. In an animal model of hypertension, M-ANP lowers BP via multiple mechanisms, including vasodilatation, diuresis, and inhibition of aldosterone. Importantly, M-ANP enhances both glomerular filtration rate and renal blood flow despite reductions in BP. The pluripotent BP-lowering actions and concomitant enhancement of renal function associated with M-ANP are highly attractive characteristics for an antihypertensive agent and underscore the therapeutic potential of M-ANP. M-ANP currently is heading into clinical testing, which may advance this novel strategy for human hypertension.",
"genre": "article",
"id": "sg:pub.10.1007/s11906-011-0244-5",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1021183",
"issn": [
"1522-6417",
"1534-3111"
],
"name": "Current Hypertension Reports",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "14"
}
],
"keywords": [
"atrial natriuretic peptide",
"renal blood flow",
"glomerular filtration rate",
"natriuretic peptide",
"filtration rate",
"blood flow",
"higher plasma atrial natriuretic peptide",
"plasma atrial natriuretic peptide",
"action of ANP",
"suppression of aldosterone",
"inhibition of aldosterone",
"BP-lowering action",
"sympathetic nervous system",
"blood pressure regulation",
"recent human studies",
"cardiorenal actions",
"systemic vasodilatation",
"renal function",
"antihypertensive agents",
"human hypertension",
"BP regulation",
"lower risk",
"human studies",
"hypertension",
"nervous system",
"animal models",
"clinical testing",
"pressure regulation",
"therapeutic potential",
"vasodilatation",
"aldosterone",
"diuresis",
"protein therapy",
"multiple mechanisms",
"therapy",
"inhibition",
"peptides",
"novel strategy",
"concomitant enhancement",
"proteolytic degradation",
"action",
"risk",
"role",
"association",
"regulation",
"rate",
"suppression",
"agents",
"fundamental role",
"testing",
"study",
"reduction",
"BP",
"mechanism",
"function",
"addition",
"enhancement",
"development",
"strategies",
"potential",
"characteristics",
"flow",
"model",
"system",
"degradation",
"properties",
"attractive characteristics"
],
"name": "M-Atrial Natriuretic Peptide: A Novel Antihypertensive Protein Therapy",
"pagination": "62-69",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1012051007"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s11906-011-0244-5"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"22135207"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s11906-011-0244-5",
"https://app.dimensions.ai/details/publication/pub.1012051007"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:08",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_539.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s11906-011-0244-5"
}
]Download the RDF metadata as:Â json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11906-011-0244-5'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11906-011-0244-5'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11906-011-0244-5'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11906-011-0244-5'
This table displays all metadata directly associated to this object as RDF triples.
229 TRIPLES
22 PREDICATES
114 URIs
99 LITERALS
21 BLANK NODES